We are live on ! Find out more
ID

Integral Derivatives Portfolio holdings

AUM $4.07B
1-Year Est. Return 19.81%
This Fund
S&P 500
This Quarter Est. Return
+13.15%
1 Year Est. Return
+19.81%
3 Year Est. Return
+45.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.24B
AUM Growth
–
Cap. Flow
+$922M
Cap. Flow %
12.73%
Top 10 Hldgs %
35.17%
Holding
1,448
New
1,447
Increased
–
Reduced
–
Closed
–
Avg Time Held Equity + Options
0 quarters
Top 10 Avg Time Held Equity + Options
0 quarters
Top 20 Avg Time Held Equity + Options
0 quarters
Avg Time Held Equity only
0 quarters
Top 10 Avg Time Held Equity only
0 quarters
Top 20 Avg Time Held Equity only
0 quarters

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$172M
2
PG icon
Procter & Gamble
PG
+$85M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$49.2M
4
BKNG icon
Booking.com
BKNG
+$43.7M
5
CAT icon
Caterpillar
CAT
+$20.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 87.18%
2 Technology 3.29%
3 Energy 2.41%
4 Consumer Discretionary 1.52%
5 Communication Services 1.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MM
1426
PUT
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
$73K ﹤0.01%
+10,000
New +$67.5K
2013 Q4
0 quarters
NSU
1427
DELISTED
Nevsun Resources Ltd.
NSU
$66K ﹤0.01%
+20,000
New +$66.4K
2013 Q4
0 quarters
HNR
1428
DELISTED
Harvest Natural Resources
HNR
$63K ﹤0.01%
+3,478
New +$62.1K
2013 Q4
0 quarters
AMRN icon
1429
CALL
Amarin Corp
AMRN
$245M
$59K ﹤0.01%
+1,500
New +$77.7K
2013 Q4
0 quarters
MDGL icon
1430
PUT
Madrigal Pharmaceuticals
MDGL
$10.4B
$52K ﹤0.01%
+286
New +$52.4K
2013 Q4
0 quarters
ACHN
1431
PUT
DELISTED
Achillion Pharmaceuticals
ACHN
$52K ﹤0.01%
+15,600
New +$45.3K
2013 Q4
0 quarters
GFI icon
1432
Gold Fields
GFI
$32.4B
$49K ﹤0.01%
+15,173
New +$62.1K
2013 Q4
0 quarters
EXK icon
1433
PUT
Endeavour Silver
EXK
$2.44B
$48K ﹤0.01%
+13,100
New +$51K
2013 Q4
0 quarters
IMMU
1434
PUT
DELISTED
Immunomedics Inc
IMMU
$46K ﹤0.01%
+10,000
New +$44.5K
2013 Q4
0 quarters
NIHD
1435
DELISTED
NII HOLDINGS INC CL B
NIHD
$43K ﹤0.01%
+15,702
New +$57.9K
2013 Q4
0 quarters
FRO icon
1436
PUT
Frontline
FRO
$13.1B
$41K ﹤0.01%
+2,200
New +$30.2K
2013 Q4
0 quarters
FXEN
1437
DELISTED
FX ENERGY INC
FXEN
$37K ﹤0.01%
+10,000
New +$34.1K
2013 Q4
0 quarters
FXEN
1438
PUT
DELISTED
FX ENERGY INC
FXEN
$37K ﹤0.01%
+10,000
New +$34.1K
2013 Q4
0 quarters
CASC
1439
CALL
DELISTED
Cascadian Therapeutics, Inc.
CASC
$36K ﹤0.01%
+3,450
New +$38.6K
2013 Q4
0 quarters
FBIO icon
1440
PUT
Fortress Biotech
FBIO
$65M
$32K ﹤0.01%
+800
New +$30.9K
2013 Q4
0 quarters
MTL
1441
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$30K ﹤0.01%
+5,775
New +$31.7K
2013 Q4
0 quarters
HMY icon
1442
PUT
Harmony Gold Mining
HMY
$10.5B
$26K ﹤0.01%
+10,100
New +$30.3K
2013 Q4
0 quarters
STSI
1443
CALL
DELISTED
STAR SCIENTIFIC INC
STSI
$24K ﹤0.01%
+20,600
New +$32.8K
2013 Q4
0 quarters
AMRN icon
1444
PUT
Amarin Corp
AMRN
$245M
$20K ﹤0.01%
+515
New +$26.7K
2013 Q4
0 quarters
VGZ icon
1445
Vista Gold
VGZ
$378M
$15K ﹤0.01%
+40,000
New +$16.6K
2013 Q4
0 quarters
FU
1446
CALL
DELISTED
FAB UNIVERSAL CORP COM
FU
$10K ﹤0.01%
+10,000
New +$57.1K
2013 Q4
0 quarters
VELT
1447
DELISTED
VELTI PLC, ST HELIER ORDINARY SHARES (JERSEY)
VELT
$1K ﹤0.01%
+14,226
New +$2.77K
2013 Q4
0 quarters

Similar funds

Integral Derivatives's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for Integral Derivatives, which disclosed 1,448 positions worth $7.24B. Its ten largest holdings account for 35% of the portfolio.

Its largest position is Apple: 9,092,020 shares worth $182M.

By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, followed by Technology and Energy.

  • Integral Derivatives's largest Q4 2013 buy was Apple: 9,092,020 shares worth $182M.
  • Integral Derivatives's ten largest holdings make up 35% of its $7.24B portfolio in Q4 2013.
  • Integral Derivatives disclosed 1,448 positions in Q4 2013, its first 13F filing on record.

Based on Integral Derivatives's 13F filing for Q4 2013, filed 12 Feb 2014.